New drug trial aims to better control aggressive blood cancer
Disease control
Recruiting now
This study is testing whether a newer drug called pacritinib works better than the standard drug hydroxyurea for adults with an advanced, fast-growing type of blood cancer called chronic myelomonocytic leukemia. About 66 participants will be randomly assigned to take one of the t…
Phase: PHASE2 • Sponsor: Theradex • Aim: Disease control
Last updated Mar 10, 2026 12:52 UTC